Results 21 to 30 of 38 matches
Category 5 - DIAGNOSTIC IMAGING SERVICES
61563 - Additional Information
Whole body prostate-specific membrane antigen PET study performed for
the initial staging of intermediate to high-risk prostate adenocarcinoma, for a
previously untreated patient who is considered suitable for locoregional
therapy with curative intent
Applicable once per lifetime (R)
Fee: $1,300.00 Benefit: 75% = $975.00 85% = $1,206.80
(See para IN.0.17, IN.0.19 of explanatory notes to this Category)
Category 5 - DIAGNOSTIC IMAGING SERVICES
61564 - Additional Information
Whole body prostate-specific membrane antigen PET study performed for
the restaging of recurrent prostate adenocarcinoma, for a patient who:
(a) has undergone prior locoregional therapy; and
(b) is considered suitable for further locoregional therapy to determine
appropriate therapeutic pathways and timing of treatment initiation
Applicable twice per lifetime (R)
Fee: $1,300.00 Benefit: 75% = $975.00 85% = $1,206.80
(See para IN.0.17, IN.0.19 of explanatory notes to this Category)
Category 5 - DIAGNOSTIC IMAGING SERVICES
61565 - Additional Information
Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy. (R)
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
(See para IN.0.19 of explanatory notes to this Category)
Category 5 - DIAGNOSTIC IMAGING SERVICES
61571 - Additional Information
Whole body FDG PET study, for the further primary staging of patients with histologically proven carcinoma of the uterine cervix, at FIGO stage IB2 or greater by conventional staging, prior to planned radical radiation therapy or combined modality therapy with curative intent. (R)
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
Category 5 - DIAGNOSTIC IMAGING SERVICES
61575 - Additional Information
Whole body FDG PET study, for the further staging of patients with confirmed local recurrence of carcinoma of the uterine cervix considered suitable for salvage pelvic chemoradiotherapy or pelvic exenteration with curative intent. (R)
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
Category 5 - DIAGNOSTIC IMAGING SERVICES
61577 - Additional Information
Whole body FDG PET study, performed for the staging of proven oesophageal or GEJ carcinoma, in patients considered suitable for active therapy (R).
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
Category 5 - DIAGNOSTIC IMAGING SERVICES
61598 - Additional Information
Whole body FDG PET study performed for the staging of biopsy-proven newly diagnosed or recurrent head and neck cancer (R).
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
Category 5 - DIAGNOSTIC IMAGING SERVICES
61604 - Additional Information
Whole body FDG PET study performed for the evaluation of patients with suspected residual head and neck cancer after definitive treatment, and who are suitable for active therapy (R).
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
Category 5 - DIAGNOSTIC IMAGING SERVICES
61610 - Additional Information
Whole body FDG PET study performed for the evaluation of metastatic squamous cell carcinoma of unknown primary site involving cervical nodes (R).
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
Category 5 - DIAGNOSTIC IMAGING SERVICES
61612 - Additional Information
Whole body FDG PET study for the initial staging of eligible cancer types, for a patient who is considered suitable for active therapy, if:
(a) the eligible cancer type is:
(i) a rare or uncommon cancer (less than 12 cases per 100,000 persons per year); and
(ii) a typically FDG‑avid cancer; and
(b) there is at least a 10% likelihood that the PET study result will inform a significant change in management for the patient
Applicable once per cancer diagnosis (R)
Fee: $953.00 Benefit: 75% = $714.75 85% = $859.80
(See para IN.0.17, IN.0.19 of explanatory notes to this Category)
Results 21 to 30 of 38 matches
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change